AI-powered wearable patch for heart and lung monitoring
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Lungs & breathing clinical trials.
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are able to wear a portable heart monitor (called a Holter monitor) for at least a day.
- You are not currently using a breathing machine, heart pump, or kidney dialysis.
- You do not have a bad skin reaction to sticky medical patches.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a wearable heart monitor and special software can check the health of your whole heart and assess your risk of future heart problems. It may help doctors create more personalized care plans.
This study uses an AI-powered wearable monitor to check how well your heart pumps blood (ejection fraction) from a simple EKG recording. It may help doctors quickly assess heart function without extra tests.
This study uses a wearable patch to monitor heart-related signs in people with heart conditions. It aims to learn more about how these conditions progress, which could help improve future care.
This study tests a wearable patch (like a smart bandage) that tracks your heart health at home. It's for children and teens with heart failure to help doctors monitor them without frequent hospital visits.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This trial checks whether a medical patch called HEMOTAG can help doctors predict or track how patients do shortly after a hospital stay for worsening heart failure. It may help improve early monitoring and treatment decisions after discharge.
Hear when a new Heart Decompensation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.